Lung tissues in patients with systemic sclerosis have gene expression patterns unique to pulmonary fibrosis and pulmonary hypertension.
about
Microarray analysis in pulmonary hypertensionManagement of Systemic-Sclerosis-Associated Interstitial Lung DiseaseDust events, pulmonary diseases and immune systemPersonalized medicine: applying 'omics' to lung fibrosisUpdate on scleroderma-associated interstitial lung diseaseEvolving genomic approaches to idiopathic pulmonary fibrosis: moving beyond genesGene expression profiling offers insights into the role of innate immune signaling in SScValidated prediction of pro-invasive growth factors using a transcriptome-wide invasion signature derived from a complex 3D invasion assayDissecting the heterogeneity of skin gene expression patterns in systemic sclerosisEstrogen receptor-dependent attenuation of hypoxia-induced changes in the lung genome of pulmonary hypertension rats.Matrix metalloproteinase-19 is a key regulator of lung fibrosis in mice and humansDifferences in irradiated lung gene transcription between fibrosis-prone C57BL/6NHsd and fibrosis-resistant C3H/HeNHsd mice.Scleroderma lung diseasePathogenesis of idiopathic pulmonary fibrosis: review of recent findings.Simultaneous downregulation of KLF5 and Fli1 is a key feature underlying systemic sclerosis.Cartilage oligomeric matrix protein in idiopathic pulmonary fibrosis.Integrating mechanisms of pulmonary fibrosisReview: interstitial lung disease associated with systemic sclerosis and idiopathic pulmonary fibrosis: how similar and distinct?A novel genomic signature with translational significance for human idiopathic pulmonary fibrosis.Association of Interferon- and transforming growth factor β-regulated genes and macrophage activation with systemic sclerosis-related progressive lung fibrosis.Interleukin-6/interleukin-21 signaling axis is critical in the pathogenesis of pulmonary arterial hypertension.Inhalation of sulfur mustard causes long-term T cell-dependent inflammation: possible role of Th17 cells in chronic lung pathology.RNA Sequencing Analysis Detection of a Novel Pathway of Endothelial Dysfunction in Pulmonary Arterial Hypertension.Molecular network of important genes for systemic sclerosis-related progressive lung fibrosis.The effect of environmental enrichment on substantia nigra gene expression after traumatic brain injury in rats.Integrating molecular genetics and systems approaches to pulmonary vascular diseases.Endothelial GATA-6 deficiency promotes pulmonary arterial hypertension.miR-155 in the progression of lung fibrosis in systemic sclerosis.Microarray profiling reveals suppressed interferon stimulated gene program in fibroblasts from scleroderma-associated interstitial lung disease.Cytokine mediated tissue fibrosisMatrix Producing Cells in Chronic Kidney Disease: Origin, Regulation, and Activation.Genetic architecture of human fibrotic diseases: disease risk and disease progression.Skin gene expression correlates of severity of interstitial lung disease in systemic sclerosis.Overexpression of c-Met and CD44v6 receptors contributes to autocrine TGF-β1 signaling in interstitial lung diseaseUnderstanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities.The Th17 pathway and inflammatory diseases of the intestines, lungs, and skinA novel multi-network approach reveals tissue-specific cellular modulators of fibrosis in systemic sclerosis.Capturing the heterogeneity in systemic sclerosis with genome-wide expression profiling.β-catenin signaling: a novel mediator of fibrosis and potential therapeutic target.Insulin-like growth factor binding proteins-3 and -5: central mediators of fibrosis and promising new therapeutic targets.
P2860
Q26748607-62E30C97-7E35-4BAA-9C13-F3C4ADFA5DEBQ26799573-C8D2438C-EEC6-4031-A827-E552FD792595Q26852090-578C14B9-CD90-4745-B64D-ED530042C415Q26866919-AF96086F-D65C-44CF-8901-F8F98566C2BCQ27016132-4366CAF4-13E0-49FC-9E77-E8B8240CC901Q27025625-D6216482-F074-4E0B-B605-63F36C6AE9EDQ28083733-42A3ABDB-FB3F-420E-A8B2-9797EF08E154Q28385088-1E4AF8A7-138F-4B16-A223-E4AB25CBAF0AQ30845649-F909C23A-5527-4ECC-A1B1-CAB4D318F818Q33738546-54371C42-FFB1-4E1B-872E-950F0FCA2A33Q33745690-8C8265D8-05A8-45FB-8673-F06B4DB5B184Q33820556-5851076A-D84E-4846-9E00-15B795EB448DQ33919119-C374701E-4FFF-4077-8EFA-153E54E11CB6Q34019921-ABF0224E-8A8A-4D50-84F9-CD58516ADE16Q34721223-BED5107C-C81E-43C6-8719-43F3E762022CQ35077927-948FEB8F-AE4B-4673-A8F6-FB86F6B87632Q35106452-66BA7595-6954-4EDA-A333-15424C73FE31Q35121494-26280B5C-B4AD-415C-9B01-DFDAFC9FC8FAQ35207651-A39D1F14-A5ED-484A-9135-1A22A99B30D1Q35628723-9A8B1789-CC54-4B8A-BD58-8CEF00CF0B71Q35644609-A397CD7E-CC16-4365-BF12-645C0F4DC6ACQ35923173-1021015D-7CFB-47FD-8109-99F631C09BE1Q36096312-6304DFF5-BE25-4EDA-94CE-529829826621Q36130791-5DBE4DA4-C307-4F94-8275-77EFE3E8AEF5Q36629436-E969B641-2EA1-48D3-92C4-4F58F442E52EQ36810797-8C0488E9-89A6-413D-9F01-682BC6FF6377Q36888302-B8BF6765-F169-4F52-8669-9E92D6A168BCQ37064457-8B50B9C5-4DB3-4D29-AF9B-512D1C978D10Q37112937-01E99A57-DF0B-4446-B6D7-882D7745D2D4Q37209512-741852AA-81E6-409F-A1AC-B41850AAFEF9Q37364008-49AA2232-BFDA-45BC-BE5E-EACCDDD7B86BQ37400152-4826A365-B251-41BC-87F9-8DDD0A380D1DQ37503878-9CF05A67-8E9E-483F-AF70-CD6DE8F115C7Q37635850-C7A3ECE4-9091-4FAF-97BA-159A14A66229Q37638268-4C8E8825-FD91-405D-8AF2-8D9AACB2722AQ37662888-06A6A385-1E26-4983-B2EC-FC3B8E4C3BA5Q37717578-17011618-34A2-481F-BC08-B946375CCA2CQ37905787-81365F61-28D6-40D7-A66C-F85DCF7A80B3Q37925433-DC81710A-9FCA-4062-B6AB-90BD62B75EF3Q38026844-C7150B01-1AEB-42D1-836A-F07650966D56
P2860
Lung tissues in patients with systemic sclerosis have gene expression patterns unique to pulmonary fibrosis and pulmonary hypertension.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Lung tissues in patients with ...... is and pulmonary hypertension.
@ast
Lung tissues in patients with ...... is and pulmonary hypertension.
@en
type
label
Lung tissues in patients with ...... is and pulmonary hypertension.
@ast
Lung tissues in patients with ...... is and pulmonary hypertension.
@en
prefLabel
Lung tissues in patients with ...... is and pulmonary hypertension.
@ast
Lung tissues in patients with ...... is and pulmonary hypertension.
@en
P2093
P2860
P356
P1476
Lung tissues in patients with ...... sis and pulmonary hypertension
@en
P2093
Carol A Feghali-Bostwick
Eileen Hsu
Haiwen Shi
Joseph M Pilewski
Rick M Jordan
P2860
P304
P356
10.1002/ART.30159
P577
2011-03-01T00:00:00Z